Michele Del Vecchio

11PUBLICATIONS
92CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 04, 2026
Circulating thymidine kinase activity predicts survival and optimal treatment sequencing in BRAF-mutated metastatic melanoma in the SECOMBIT trial.

|Jun 26, 2026
Neoadjuvant Therapy and the Evolving Management of Resectable Advanced Melanoma.

|Jun 26, 2026
Adjuvant Approaches in Fully Resected Stage III and IV Cutaneous Melanoma: Where Are We Now?

|Jun 12, 2026
Adjuvant Therapy for High-Risk Stage II Cutaneous Melanoma: Insights and Future Directions.

|May 27, 2026
New Perspectives and Open Issues in the Adjuvant and Neoadjuvant Treatment of Melanoma.

|May 04, 2026
CAR-engineering of innate and innate-like immune cells: a new horizon in adoptive cell therapy for solid tumors.

Pageof 2

Frequent Collaborators

5 joint publications

Paolo Fava

5 joint publications

Alessandro Minisini

4 joint publications

Lorenza Di Guardo

4 joint publications

Gabriele Roccuzzo